YAO Houzong (姚后宗)

Research Output

  1. 2019
  2. Published

    Synthesis and Cytotoxic Study of a Platinum(IV) Anticancer Prodrug with Selectivity toward Luteinizing Hormone-Releasing Hormone (LHRH) Receptor-Positive Cancer Cells

    Yao, H., Xu, Z., Li, C., Tse, M., Tong, Z. & Zhu, G., 19 Aug 2019, In : Inorganic Chemistry. 58, 16, p. 11076−11084

    Research output: Journal Publications and Reviews (RGC: 21, 22, 62)21_Publication in refereed journalNot applicablepeer-review

    Scopus citations: 1
    Check@CityULib
  3. 2017
  4. Chemical Modifications of Nucleic Acid Aptamers for Therapeutic Purposes

    Ni, S., Yao, H., Wang, L., Lu, J., Jiang, F., Lu, A. & Zhang, G., Aug 2017, In : International Journal of Molecular Sciences. 18, 8, p. 1-21 1683.

    Research output: Journal Publications and Reviews (RGC: 21, 22, 62)21_Publication in refereed journalNot applicablepeer-review

    Scopus citations: 60
    Check@CityULib
  5. 2016
  6. Prodrug Strategies for Paclitaxel

    Meng, Z., Lv, Q., Lu, J., Yao, H., Lv, X., Jiang, F., Lu, A. & 1 othersZhang, G., 2016, In : International Journal of Molecular Sciences. 17, 5, 796.

    Research output: Journal Publications and Reviews (RGC: 21, 22, 62)21_Publication in refereed journalNot applicablepeer-review

    Scopus citations: 14
    Check@CityULib